Research Article

SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma

Figure 2

The expression of SHISA3 assessed using quantitative RT-PCR assay. (a) Expression levels of SHISA3 in LSCC and adjacent normal samples (n = 35). The SHISA3 expression level was significantly lower in tumor tissues than in corresponding normal tissues . (b) Expression levels of SHISA3 in the methylation group (n = 26) and unmethylation group (n = 9). The SHISA3 expression levels were significantly lower in the methylation group compared with the unmethylation group .
(a)
(b)